Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.40
+0.47 (6.78%)
Nov 21, 2024, 1:19 PM EST - Market open
Silence Therapeutics Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | - | -43.27 | -40.49 | -39.41 | -32.55 | -19.58 | Upgrade
|
| Depreciation & Amortization | - | 0.5 | 0.48 | 0.43 | 0.5 | 0.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0 | 0 | Upgrade
|
| Stock-Based Compensation | - | 13.05 | 10.25 | 8.63 | 4.4 | 0.58 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | -4.86 | - | Upgrade
|
| Other Operating Activities | - | 2.03 | -7.44 | -1.69 | 3.09 | -0.84 | Upgrade
|
| Change in Accounts Receivable | - | 0.31 | -0.58 | 27.48 | -29.3 | -0 | Upgrade
|
| Change in Accounts Payable | - | 0.04 | 1.45 | 2.41 | 1.3 | 3.06 | Upgrade
|
| Change in Unearned Revenue | - | -8.28 | -4.4 | 8.37 | 50.39 | 17.99 | Upgrade
|
| Change in Other Net Operating Assets | - | -1.97 | -4.23 | 0.59 | -3.73 | 0.04 | Upgrade
|
| Operating Cash Flow | - | -39.35 | -45.46 | 6.81 | -10.78 | 1.73 | Upgrade
|
| Capital Expenditures | - | -0.05 | -0.14 | -1.31 | -0.51 | -0.01 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.3 | -0.02 | -0 | - | Upgrade
|
| Investment in Securities | - | 15.52 | -16.13 | 10 | 10 | -15 | Upgrade
|
| Other Investing Activities | - | 0.96 | 0.02 | 0.01 | 0.13 | -0.01 | Upgrade
|
| Investing Cash Flow | - | 16.43 | -16.54 | 8.68 | 9.62 | -15.02 | Upgrade
|
| Long-Term Debt Repaid | - | -0.17 | -0.19 | -0.21 | -0.4 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.17 | -0.19 | -0.21 | -0.4 | - | Upgrade
|
| Issuance of Common Stock | - | 25.33 | 43.24 | 30.92 | 15.83 | 5.27 | Upgrade
|
| Financing Cash Flow | - | 25.16 | 43.05 | 30.71 | 15.43 | 5.27 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -3.02 | 0.23 | -0.11 | -0.34 | 0.04 | Upgrade
|
| Net Cash Flow | - | -0.79 | -18.72 | 46.09 | 13.93 | -7.98 | Upgrade
|
| Free Cash Flow | - | -39.4 | -45.6 | 5.5 | -11.29 | 1.72 | Upgrade
|
| Free Cash Flow Margin | - | -155.25% | -260.53% | 44.26% | -206.00% | 704.10% | Upgrade
|
| Free Cash Flow Per Share | - | -1.06 | -1.42 | 0.19 | -0.41 | 0.07 | Upgrade
|
| Cash Income Tax Paid | - | 0.64 | - | - | -3.02 | -2.31 | Upgrade
|
| Levered Free Cash Flow | - | -22.88 | -26.39 | -4.96 | -34.13 | -8.62 | Upgrade
|
| Unlevered Free Cash Flow | - | -22.85 | -26.36 | -4.96 | -34.12 | -8.6 | Upgrade
|
| Change in Net Working Capital | 0.77 | 5.36 | 6.28 | -15.95 | 19.13 | -4.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.